175 related articles for article (PubMed ID: 12496477)
1. Mutations in the BRCT domain confer temperature sensitivity to BRCA1 in transcription activation.
Carvalho MA; Billack B; Chan E; Worley T; Cayanan C; Monteiro AN
Cancer Biol Ther; 2002; 1(5):502-8. PubMed ID: 12496477
[TBL] [Abstract][Full Text] [Related]
2. A naturally occurring allele of BRCA1 coding for a temperature-sensitive mutant protein.
Worley T; Vallon-Christersson J; Billack B; Borg A; Monteiro AN
Cancer Biol Ther; 2002; 1(5):497-501. PubMed ID: 12496476
[TBL] [Abstract][Full Text] [Related]
3. Functional assay for BRCA1: mutagenesis of the COOH-terminal region reveals critical residues for transcription activation.
Hayes F; Cayanan C; Barillà D; Monteiro AN
Cancer Res; 2000 May; 60(9):2411-8. PubMed ID: 10811118
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a novel trans-activation domain of BRCA1 that functions in concert with the BRCA1 C-terminal (BRCT) domain.
Hu YF; Miyake T; Ye Q; Li R
J Biol Chem; 2000 Dec; 275(52):40910-5. PubMed ID: 11067843
[TBL] [Abstract][Full Text] [Related]
5. A functional comparison of BRCA1 C-terminal domains in transcription activation and chromatin remodeling.
Miyake T; Hu YF; Yu DS; Li R
J Biol Chem; 2000 Dec; 275(51):40169-73. PubMed ID: 11016938
[TBL] [Abstract][Full Text] [Related]
6. Creating a tool-kit for exploring BRCA1 function.
Parvin JD
Cancer Biol Ther; 2002; 1(5):509-10. PubMed ID: 12496478
[No Abstract] [Full Text] [Related]
7. Structural basis to characterise transactivation domain of BRCA1.
Yadav LR; Biswal MN; Hosur MV; Kumar NS; Varma AK
J Biomol Struct Dyn; 2017 Jan; 35(1):1-7. PubMed ID: 26727155
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a transcriptional activation function of BRCA1 C-terminal region.
Monteiro AN; August A; Hanafusa H
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13595-9. PubMed ID: 8942979
[TBL] [Abstract][Full Text] [Related]
9. Impact of amino acid substitutions at secondary structures in the BRCT domains of the tumor suppressor BRCA1: Implications for clinical annotation.
Fernandes VC; Golubeva VA; Di Pietro G; Shields C; Amankwah K; Nepomuceno TC; de Gregoriis G; Abreu RBV; Harro C; Gomes TT; Silva RF; Suarez-Kurtz G; Couch FJ; Iversen ES; Monteiro ANA; Carvalho MA
J Biol Chem; 2019 Apr; 294(15):5980-5992. PubMed ID: 30765603
[TBL] [Abstract][Full Text] [Related]
10. The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter.
Chai YL; Cui J; Shao N; Shyam E; Reddy P; Rao VN
Oncogene; 1999 Jan; 18(1):263-8. PubMed ID: 9926942
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1.
Williams RS; Green R; Glover JN
Nat Struct Biol; 2001 Oct; 8(10):838-42. PubMed ID: 11573086
[TBL] [Abstract][Full Text] [Related]
12. Structural consequences of a cancer-causing BRCA1-BRCT missense mutation.
Williams RS; Glover JN
J Biol Chem; 2003 Jan; 278(4):2630-5. PubMed ID: 12427738
[TBL] [Abstract][Full Text] [Related]
13. Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach.
Tischkowitz M; Hamel N; Carvalho MA; Birrane G; Soni A; van Beers EH; Joosse SA; Wong N; Novak D; Quenneville LA; Grist SA; ; Nederlof PM; Goldgar DE; Tavtigian SV; Monteiro AN; Ladias JA; Foulkes WD
Eur J Hum Genet; 2008 Jul; 16(7):820-32. PubMed ID: 18285836
[TBL] [Abstract][Full Text] [Related]
14. Structure-based assessment of missense mutations in human BRCA1: implications for breast and ovarian cancer predisposition.
Mirkovic N; Marti-Renom MA; Weber BL; Sali A; Monteiro AN
Cancer Res; 2004 Jun; 64(11):3790-7. PubMed ID: 15172985
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of missense variations in the BRCT domain of BRCA1 by structural and functional assays.
Lee MS; Green R; Marsillac SM; Coquelle N; Williams RS; Yeung T; Foo D; Hau DD; Hui B; Monteiro AN; Glover JN
Cancer Res; 2010 Jun; 70(12):4880-90. PubMed ID: 20516115
[TBL] [Abstract][Full Text] [Related]
16. Characterization of cancer-linked BRCA1-BRCT missense variants and their interaction with phosphoprotein targets.
Drikos I; Nounesis G; Vorgias CE
Proteins; 2009 Nov; 77(2):464-76. PubMed ID: 19452558
[TBL] [Abstract][Full Text] [Related]
17. Detection of a novel mutation in exon 20 of the BRCA1 gene.
Chakraborty A; Katarkar A; Chaudhuri K; Mukhopadhyay A; Basak J
Cell Mol Biol Lett; 2013 Dec; 18(4):631-8. PubMed ID: 24297685
[TBL] [Abstract][Full Text] [Related]
18. Multimodel assessment of BRCA1 mutations in Taiwanese (ethnic Chinese) women with early-onset, bilateral or familial breast cancer.
Kuo WH; Lin PH; Huang AC; Chien YH; Liu TP; Lu YS; Bai LY; Sargeant AM; Lin CH; Cheng AL; Hsieh FJ; Hwu WL; Chang KJ
J Hum Genet; 2012 Feb; 57(2):130-8. PubMed ID: 22277901
[TBL] [Abstract][Full Text] [Related]
19. Cancer predisposing mutations in BRCT domains.
di Masi A; Gullotta F; Cappadonna V; Leboffe L; Ascenzi P
IUBMB Life; 2011 Jul; 63(7):503-12. PubMed ID: 21698754
[TBL] [Abstract][Full Text] [Related]
20. Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1.
Williams RS; Lee MS; Hau DD; Glover JN
Nat Struct Mol Biol; 2004 Jun; 11(6):519-25. PubMed ID: 15133503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
